Back to Search
Start Over
Cypress, forest NDA in FMS puts drug in line for 'churn'
- Source :
- Bioworld Financial Watch. Jan 7, 2008, Vol. 16 Issue 1, p1, 3 p.
- Publication Year :
- 2008
-
Abstract
- When Pfizer Inc. won U.S. approval of its alpha-2 delta ligand Lyrica, people with fibromyalgia syndrome (FMS) gained their first official therapy for the painful, head-to-toe disorder, which brings a [...]
- Subjects :
- Pfizer Inc. -- Product information
Cypress Bioscience Inc. -- Product development
Cypress Bioscience Inc. -- Alliances and partnerships
Forest Laboratories Inc. -- Product development
Forest Laboratories Inc. -- Alliances and partnerships
Pharmaceutical industry -- Product information
Pharmaceutical industry -- Product development
Pharmaceutical industry -- Alliances and partnerships
Drug approval -- Standards
Fibromyalgia -- Care and treatment
Cooperative agreement for product development
Banking, finance and accounting industries
Biotechnology industry
Lyrica (Medication) -- Complications and side effects
Subjects
Details
- Language :
- English
- ISSN :
- 15410579
- Volume :
- 16
- Issue :
- 1
- Database :
- Gale General OneFile
- Journal :
- Bioworld Financial Watch
- Publication Type :
- News
- Accession number :
- edsgcl.173385981